Stockholders' Deficit	6 Months Ended
Jun. 30, 2017
Stockholders' Deficit [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 8 – STOCKHOLDERS’ DEFICIT COMMON STOCK For the six months ended June 30, 2017, the Company sold 22,800,000 restricted shares of common stock at $0.01 per share for total proceeds of $228,000. For the six months ended June 30, 2017, the Company granted 1,143,283 restricted shares of common stock for business development services. The Company valued the shares based on the closing price of the Company common stock on those days during which such services were performed. This resulted in $22,585 of expense for the six months ended June 30, 2017. COMMON STOCK WARRANTS The Company did not issue warrants for the six months ended June 30, 2017 and 2016 and no warrants were exercised. Twelve warrants, exercisable in the aggregate for a total of 3,650,000 shares of common stock, expired prior to exercise during the six months ended June 30, 2016. As of June 30, 2017, there were no warrants outstanding.

Stockholders' Deficit

6 Months Ended

Jun. 30, 2017

NOTE 8 – STOCKHOLDERS’ DEFICIT

COMMON STOCK

For the six months ended June 30, 2017, the Company sold 22,800,000 restricted shares of common stock at $0.01 per share for total proceeds of $228,000.

For the six months ended June 30, 2017, the Company granted 1,143,283 restricted shares of common stock for business development services. The Company valued the shares based on the closing price of the Company common stock on those days during which such services were performed. This resulted in $22,585 of expense for the six months ended June 30, 2017.

COMMON STOCK WARRANTS

The Company did not issue warrants for the six months ended June 30, 2017 and 2016 and no warrants were exercised. Twelve warrants, exercisable in the aggregate for a total of 3,650,000 shares of common stock, expired prior to exercise during the six months ended June 30, 2016. As of June 30, 2017, there were no warrants outstanding.